Shen, Minhong, Shanshan Xie, Michelle Rowicki, Sven Michel, Yong Wei, Xiang Hang, Liling Wan, et al. (2021) 2021. “Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis”. Cancer Res 81 (4): 1014-25. doi:10.1158/0008-5472.CAN-20-1876.

Pham, Kien, Do Huynh, Le Le, Daniel Delitto, Lei Yang, Jing Huang, Yibin Kang, et al. (2020) 2020. “E-Cigarette Promotes Breast Carcinoma Progression and Lung Metastasis: Macrophage-Tumor Cells Crosstalk and the Role of CCL5 and VCAM-1”. Cancer Lett 491: 132-45. doi:10.1016/j.canlet.2020.08.010.

Li, Feng, Benjamin Tiede, Joan Massagué, and Yibin Kang. (2007) 2007. “Beyond Tumorigenesis: Cancer Stem Cells in Metastasis.”. Cell Res 17 (1): 3-14. doi:10.1038/sj.cr.7310118.

Korpal, Manav, and Yibin Kang. (2010) 2010. “Targeting the Transforming Growth Factor-Beta Signalling Pathway in Metastatic Cancer.”. Eur J Cancer 46 (7): 1232-40. doi:10.1016/j.ejca.2010.02.040.

Lu, Xin, Bryson Bennet, Euphemia Mu, Joshua Rabinowitz, and Yibin Kang. (2010) 2010. “Metabolomic Changes Accompanying Transformation and Acquisition of Metastatic Potential in a Syngeneic Mouse Mammary Tumor Model.”. J Biol Chem 285 (13): 9317-21. doi:10.1074/jbc.C110.104448.

Lu, Xin, and Yibin Kang. (2009) 2009. “Cell Fusion As a Hidden Force in Tumor Progression.”. Cancer Res 69 (22): 8536-9. doi:10.1158/0008-5472.CAN-09-2159.

Hu, Guohong, Yong Wei, and Yibin Kang. (2009) 2009. “The Multifaceted Role of MTDH AEG-1 in Cancer Progression.”. Clin Cancer Res 15 (18): 5615-20. doi:10.1158/1078-0432.CCR-09-0049.

Sethi, Nilay, and Yibin Kang. (2011) 2011. “Dysregulation of Developmental Pathways in Bone Metastasis.”. Bone 48 (1): 16-22. doi:10.1016/j.bone.2010.07.005.

Smith, Heath, and Yibin Kang. (2013) 2013. “The Metastasis-Promoting Roles of Tumor-Associated Immune Cells.”. J Mol Med (Berl) 91 (4): 411-29. doi:10.1007/s00109-013-1021-5.

Wan, Liling, Guohong Hu, Yong Wei, Min Yuan, Roderick Bronson, Qifeng Yang, Javed Siddiqui, Kenneth Pienta, and Yibin Kang. (2014) 2014. “Genetic Ablation of Metadherin Inhibits Autochthonous Prostate Cancer Progression and Metastasis.”. Cancer Res 74 (18): 5336-47. doi:10.1158/0008-5472.CAN-14-1349.

Li, Zhuo, and Yibin Kang. (2016) 2016. “Emerging Therapeutic Targets in Metastatic Progression: A Focus on Breast Cancer.”. Pharmacol Ther 161: 79-96. doi:10.1016/j.pharmthera.2016.03.003.